当前位置:首页 - 行情中心 - 康美药业(600518) - 财务分析 - 利润表

康美药业

(600518)

27.40

0.28  (1.03%)

今开:27.15最高:27.70成交:13.50万手 市盈:0.00 上证指数:3141.30   -0.42%2018-05-25
昨收:27.12 最低:27.01 换手:0.00%振幅:0.00 深证指数:10448.22  -1.10%15:29:14

集合

竞价

利润表

按照会计年度查询:
报告期2018-03-312017-12-312017-09-302017-06-30
一、营业总收入9,135,184,162.2326,476,970,977.5719,514,526,256.1513,262,364,685.61
营业收入9,135,184,162.2326,476,970,977.5719,514,526,256.1513,262,364,685.61
二、营业总成本7,465,191,929.8721,823,908,376.0915,830,436,473.5110,749,188,772.49
营业成本6,468,232,694.1418,450,146,87113,577,589,810.299,321,809,278.43
营业税金及附加68,397,768.04237,906,209.42150,201,466.08102,471,157.85
销售费用249,066,505.07740,581,081.08482,501,529.89311,116,118.44
管理费用323,849,365.341,333,729,123.44916,703,295.04583,668,235.63
财务费用308,783,481.31969,264,876672,106,353.45408,753,216.86
资产减值损失46,862,115.9792,280,215.1531,334,018.7621,370,765.28
三、其他经营收益-2,284,864.09153,201.549,785,380.315,393,023.5
允许价值变动净收益--------
投资净收益12,108,982.7483,726,546.6455,335,259.0636,805,435.65
联营、合营企业投资收益12,108,982.7483,399,039.8155,335,259.0636,805,435.65
汇兑净收益--------
四、营业利润1,694,184,607.544,834,826,903.743,758,890,065.932,564,989,048.72
营业外收入8,914,057.8911,556,101.0120,078,671.6714,328,431.67
营业外支出4,132,125.1319,682,919.329,768,399.67,592,454.63
非流动资产处置净损失----1,345,671.85635,707.45
五、利润总额1,698,966,540.34,826,700,085.433,769,200,3382,571,725,025.76
所得税281,763,845.15732,053,848.25625,711,121.83425,867,711.28
未确认的投资损失--------
六、净利润(百万元)1,423.094,100.933,150.982,151.54
少数股东损益-5,882,592.72-6,279,911.39-7,487,210.25-5,687,633.17
归属于母公司股东的净利润1,423,085,287.874,100,926,148.573,150,976,426.422,151,544,947.65
七、每股收益0.290.780.640.44
基本每股收益0.290.780.640.44
稀释每股收益0.290.780.640.44
TOP↑